166Ho-DOTMP Skeletal Targeted Radiotherapy™ as conditioning for peripheral blood stem cell transplant for patients with multiple myeloma

被引：0
作者：
Breitz, H
Wendt, R
Stabin, M
Shen, S
Rajendran, JG
Meredith, R
Martin, W
Serafini, A
Delpassand, E
Bensinger, W
Salzman, D
Ruffner, K
Goodman, M
Giralt, S
机构：
[1] NEORX Corp, Seattle, WA 98119 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Vanderbilt Univ, Nashville, TN USA
[4] Univ Alabama, Ctr Canc, Birmingham, AL USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Univ Miami, Miami, FL 33152 USA
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S291 / S292
页数：2
相关论文
共 50 条
  • [1] 166Ho-DOTMP Skeletal Targeted Radiotherapy with melphalan and autologous stem cell support for multiple myeloma
    Bensinger, W
    Giralt, S
    Goodman, M
    Salzman, D
    Ruffner, K
    Breitz, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 596S - 596S
  • [2] Holmium-166 (166Ho)-DOTMP skeletal targeted radiotherapy (STR™) with melphalan and autologous peripheral stem cell transplant (PBSCT) for multiple myeloma (MM).
    Goodman, M
    Bensinger, WI
    Giralt, S
    Salzman, D
    Ruffner, KL
    Breitz, HB
    BLOOD, 2004, 104 (11) : 264A - 264A
  • [3] Dosimetry of high dose skeletal targeted radiotherapy (STR) with 166Ho-DOTMP
    Breitz, H
    Wendt, R
    Stabin, M
    Bouchet, L
    Wessels, B
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) : 225 - 230
  • [4] 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy
    Breitz, Hazel B.
    Wendt, Richard E.
    Stabin, Michael S.
    Shen, Sui
    Erwin, William D.
    Rajendran, Joseph G.
    Eary, Janet F.
    Durack, Lawrence
    Delpassand, Ebrahim
    Martin, William
    Meredith, Ruby F.
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (03) : 534 - 542
  • [5] Long-term safety and efficacy data supporting new dosing of 166Ho-DOTMP skeletal targeted radiotherapy for multiple myeloma
    Giralt, S
    Bensinger, W
    Goodman, M
    Gray, D
    Sims, R
    Breitz, H
    BLOOD, 2003, 102 (11) : 985A - 985A
  • [6] 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma:: results of two phase 1/2 trials
    Giralt, S
    Bensinger, W
    Goodman, M
    Podoloff, D
    Eary, J
    Wendt, R
    Alexanian, R
    Weber, D
    Maloney, D
    Holmberg, L
    Rajandran, J
    Breitz, H
    Ghalie, R
    Champlin, R
    BLOOD, 2003, 102 (07) : 2684 - 2691
  • [7] Results of a retrospective single institution analysis of targeted skeletal radiotherapy with 166Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma.: Impact on transplant outcomes
    Christoforidou, Anna V.
    Saliba, Rima M.
    Williams, Patricia
    Qazilbash, Muzaffar
    Roden, Linda
    Aleman, Ana
    Weber, Donna
    Mendoza, Floralyn
    Podoloff, Donald
    Wendt, Richard, III
    Breitz, Hazel
    Alexanian, Raymond
    Champlin, Richard
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (05) : 543 - 549
  • [8] Targeted radiotherapy to the skeleton using 166HO-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancer
    Champlin, RE
    Booser, D
    Rondon, G
    Williams, PA
    Wendt, R
    Hortobagyi, G
    Ueno, N
    Podoloff, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 84 - 85
  • [9] Targeted radiotherapy to the skeleton using 166Ho-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancer
    Champlin, R
    Booser, D
    Rondon, G
    Williams, P
    Wendt, R
    Hortobagyi, G
    Ueno, N
    Podoloff, D
    BLOOD, 2004, 104 (11) : 395B - 395B
  • [10] Formulation development & stability of the 166Ho-DOTMP for high level dosages -: A skeletal targeted radiotherapeutic.
    John, EK
    Boone, J
    Hsiao, P
    Aberion, D
    Resol, E
    Bottino, B
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 267P - 267P
12345